Other factors that may contribute to nausea during retatrutide treatment include: Central nervous system effects : GLP-1 receptors are present in brain regions involved in nausea and vomiting, including the area postrema, and activation of these pathways is thought to contribute to the emetogenic effects of this drug class [15] [16] Dose escalation : Rapid increases in dose are more likely to provoke symptoms than gradual titration Individual variability : Genetic, metabolic, and lifestyle factors can influence how sensitive a person is to these effects Dietary habits : Eating large, fatty, or rich meals may worsen nausea in those taking GLP-1-based therapies These mechanisms are not unique to retatrutide and are shared to varying degrees across the entire class of incretin-based medicines
Symptoms That Should Never Be Ignored Certain severe symptoms demand immediate medical attention because they can signal a serious underlying issue
Yu YL, An DW, Yang WY, et al
Neuroendocrine Pathway Blends For laboratory models that explore peptide-receptor interactions relevant to circadian rhythm, endocrine output, or hypothalamic signaling
Although DHA cant reverse retinal damage, it may help preserve your vision and ease dry eye and eyelid inflammation
DOI: 10.3390/scipharm93020026, Wharton, S., Blevins, T., Connery, L., et al
